Education
About Us
Working with TipRanks
Follow Us
Kidswell Bio Corporation (JP:4584)
:4584
4584 Stock Chart & Stats
Day’s Range― - ―
52-Week Range¥88.00 - ¥185.00
Previous CloseN/A
Volume149.00K
Average Volume (3M)1.42M
Market Cap
¥7.11B
Enterprise Value¥5.40B
Total Cash (Recent Filing)¥624.51M
Total Debt (Recent Filing)¥1.85B
Price to Earnings (P/E)―
Beta0.93
Next Earnings
May 09, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-22.28
Shares Outstanding43,879,210
10 Day Avg. Volume1,289,100
30 Day Avg. Volume1,422,030
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
4584 FAQ
What was Kidswell Bio Corporation’s price range in the past 12 months?
Kidswell Bio Corporation lowest stock price was ¥88.00 and its highest was ¥185.00 in the past 12 months.
What is Kidswell Bio Corporation’s market cap?
Kidswell Bio Corporation’s market cap is ¥7.11B.
When is Kidswell Bio Corporation’s upcoming earnings report date?
Kidswell Bio Corporation’s upcoming earnings report date is May 09, 2025 which is in 36 days.
How were Kidswell Bio Corporation’s earnings last quarter?
Kidswell Bio Corporation released its earnings results on Feb 12, 2025. The company reported ¥1.4 earnings per share for the quarter, beating the consensus estimate of N/A by ¥1.4.
Is Kidswell Bio Corporation overvalued?
According to Wall Street analysts Kidswell Bio Corporation’s price is currently Overvalued.
Does Kidswell Bio Corporation pay dividends?
Kidswell Bio Corporation does not currently pay dividends.
What is Kidswell Bio Corporation’s EPS estimate?
Kidswell Bio Corporation’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Kidswell Bio Corporation have?
Kidswell Bio Corporation has 43,879,210 shares outstanding.
What happened to Kidswell Bio Corporation’s price movement after its last earnings report?
Kidswell Bio Corporation reported an EPS of ¥1.4 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Kidswell Bio Corporation?
Currently, no hedge funds are holding shares in JP:4584
---
Company Description
Kidswell Bio Corporation
Kidswell Bio Corporation develops pharmaceuticals for the treatment of rare and intractable diseases in Japan. Its pipeline products include GND-004 for the treatment of ophthalmic disease and oncology; GND-007 for the treatment of immunological disease; and antibodies for oncology. The company pipeline products also include GBS-001, GBS-004, and GBS-010 for oncology; GBS-005 for immunological diseases; GBS-007 and GBS-012 for ophthalmic disease; GBS-008 for infectious diseases; and GBS-011 for renal disease. In addition, its products also include GCT-101 for alveolar cleft; GCT-102 for congenital isolated hypoganglionosis; and other pipeline products for ophthalmologic diseases, cerebral palsy, peripheral nerve palsy, fracture, and spinal cord injury. The company was formerly known as Gene Techno Science Co.,Ltd. and changed its name to Kidswell Bio Corporation in July 2021. The company was incorporated in 2001 and is headquartered in Tokyo, Japan.
---
Technical Analysis
Astellas Pharma
―
Chugai Pharmaceutical Co
―
Daiichi Sankyo Company
―
Eisai Co
―
Takeda Pharmaceutical Co
―
---